Amphastar Pharmaceuticals (AMPH) Tax Rate (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted Tax Rate of 21.26% for Q2 2026, down 41.15% on a QoQ basis from 36.13% in Q1 2026, and up 15.0% year-over-year from 18.49% in Q2 2025.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Tax Rate (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals has reported Tax Rate for 14 years, with the latest figure at 21.26% in Q2 2026.
- On a quarterly basis, Tax Rate rose 15.0% year-over-year to 21.26% in Q2 2026; TTM through Jun 2026 was 22.27%, a 420.0% decrease from a year earlier, with the FY2025 full-year figure at 20.13%, down 385.0% from the prior year.
- Tax Rate was 21.26% for Q2 2026 at Amphastar Pharmaceuticals, down from 36.13% in the prior quarter.
- The five-year high for Tax Rate was 46.86% in Q4 2024, with the low at 8.62% in Q1 2024.
- Average Tax Rate over 5 years is 24.49%, with a median of 21.26% recorded in 2026.
- The sharpest annual moves came in 2025 and 2026: Tax Rate sank 2561 bps in 2025, then jumped 1806 bps in 2026.
- Over 5 years, Tax Rate stood at 44.2% in 2022, then decreased by 19 bps to 35.7% in 2023, then surged by 31 bps to 46.86% in 2024, then plunged by 55 bps to 21.26% in 2025, then advanced by 0 bps to 21.26% in 2026.
- The last three Tax Rate figures came in at 21.26% (Q2 2026), 36.13% (Q1 2026), and 21.26% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.76 Bn | 39.10 Bn | 2.15 Bn | -26.59% |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | -85.63% |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 21.32% |
| 4 | Amneal Pharmaceuticals | 5.52 Bn | 5.39 Bn | 334.51 Mn | 1.94% |
| 5 | Bausch Health Companies | 2.38 Bn | 545.13 Mn | 2.10 Bn | 25.29% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.09% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 33.43% |
| 8 | Amphastar Pharmaceuticals | 992.46 Mn | 702.34 Mn | 93.47 Mn | 21.26% |
| 9 | Fennec Pharmaceuticals | 409.53 Mn | 368.28 Mn | 17.15 Mn | 2.08% |
| 10 | RedHill Biopharma | 179.80 Mn | 179.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.26% |
| Mar 31, 2026 | 36.13% |
| Dec 31, 2025 | 21.26% |
| Sep 30, 2025 | 19.35% |
| Jun 30, 2025 | 21.11% |
| Mar 31, 2025 | 18.07% |
| Dec 31, 2024 | 46.86% |
| Sep 30, 2024 | 15.21% |
| Jun 30, 2024 | 24.47% |
| Mar 31, 2024 | 8.62% |
| Dec 31, 2023 | 35.70% |
| Sep 30, 2023 | 22.04% |
| Jun 30, 2023 | 19.46% |
| Mar 31, 2023 | 20.11% |
| Dec 31, 2022 | 44.20% |
| Sep 30, 2022 | 29.03% |
| Jun 30, 2022 | 23.98% |
| Mar 31, 2022 | 14.04% |
| Dec 31, 2021 | 26.49% |
| Sep 30, 2021 | 17.76% |